key: cord-0708596-86vasc2t
authors: Koskela, Ulla; Helve, Otto; Sarvikivi, Emmi; Helminen, Merja; Nieminen, Tea; Peltola, Ville; Renko, Marjo; Saxén, Harri; Pasma, Hanna; Pokka, Tytti; Honkila, Minna; Tapiainen, Terhi
title: Multi‐inflammatory syndrome and Kawasaki disease in children during the COVID‐19 pandemic: A nationwide register‐based study and time series analysis
date: 2021-08-04
journal: Acta Paediatr
DOI: 10.1111/apa.16051
sha: e615a92d9a3392b39d4f267153f03b7f9217d641
doc_id: 708596
cord_uid: 86vasc2t

AIM: We investigated whether the ongoing COVID‐19 pandemic was associated with the occurrence of Kawasaki disease or with multi‐inflammatory syndrome in children (MIS‐C). METHODS: This national Finnish register‐based study was based on laboratory‐confirmed severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections, MIS‐C and Kawasaki disease cases. We performed a time series analysis on the occurrence of Kawasaki disease in 2016–2020. RESULTS: In 2020, there were 5170 laboratory‐confirmed COVID‐19 cases in children under 18 years of age and five fulfilled the MIS‐C case definition. The occurrence of MIS‐C was 0.97 per 1000 (95% confidence interval: 0.31‐2.26) laboratory‐confirmed SARS‐CoV‐2 infections in children. Our time series analysis showed that Kawasaki disease cases decreased during the COVID‐19 pandemic. The seasonally adjusted incidence rate ratio was 0.49 (95% confidence interval: 0.32‐0.74) when it was compared to pre‐pandemic levels. This coincided with a reduced occurrence of respiratory infections, due to social distancing in the population. CONCLUSION: This nationwide register‐based study found that MIS‐C was a rare complication of the SARS‐CoV‐2 infection. The occurrence of Kawasaki disease and respiratory infections decreased during the pandemic. This suggests that transmissible microbes may play an important role in Kawasaki disease and social distancing may have a protective effect.

Since the global emergence of COVID-19, several centres have reported clusters of critically ill children with an inflammatory syndrome that appeared similar to Kawasaki disease. This is now commonly known as multisystem inflammatory syndrome in children (MIS-C). 1, 2 Surveillance data of childhood COVID-19 cases have indicated that children have lower rates of hospitalisation than adults.

However, MIS-C has emerged as a novel clinical entity with a broad clinical spectrum, including life-threatening cardiogenic shock. 3, 4 Several studies have reported typical symptoms of MIS-C in patient clusters. 1, [5] [6] [7] [8] [9] However, there have been limited epidemiological data about the estimated proportion of children who develop MIS-C after mild, but symptomatic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Furthermore, the overall incidence rate ratios of Kawasaki disease or Kawasaki diseaselike diagnoses have rarely been compared before and during the COVID-19 pandemic using a time series analysis. 10, 11 The aim of this register-based, nationwide study was to report the occurrence of MIS-C during the COVID-19 pandemic in 2020.

Furthermore, we wanted to compare the relative changes in the occurrence of Kawasaki disease before and during the COVID-19 pandemic using a time series analysis.

We conducted a register-based, nationwide study of the epidemiology of MIS-C in Finland in 2020 and of Kawasaki disease in 2016-2020, before and during the COVID-19 pandemic. Since August 2020, Finland has strongly recommended free SARS-CoV-2 polymerase chain reaction testing for all children with symptoms that suggest COVID-19, even if they are mild. On 16 March 2020, the Finnish Government announced a state of emergency, which included temporarily closing restaurants, food and beverage services and primary and secondary schools until 13 May. Preschools and day care centres were not closed. After the two-month closure period, schools remained mostly open for the rest of 2020.

The study was covered by the institutional research permit of the Finnish Institute for Health and Welfare, who performed the analyses. According to national legislation, informed consent was not required for this study, because it was performed with registerbased data and no patients were contacted. Other authors used and analysed the summarised register-based data. 

We defined MIS-C as follows: the patient had a registry entry in the pandemic.

• MIS-C was a rare complication of confirmed severe acute respiratory syndrome coronavirus 2, and the occurrence of Kawasaki disease decreased during the pandemic.

• This suggests that other transmissible microbes play an important role in Kawasaki disease and social distancing may have a protective effect.

intensive care wards. Kawasaki disease was defined as a patient with an entry for Kawasaki disease in the same Finnish Register.

The child's first visit for Kawasaki disease was identified, and subsequent, or duplicate, visits were excluded.

We calculated the annual incidence rates, and 95% confidence intervals (95% CIs), for both Kawasaki disease and laboratory-confirmed SARS-CoV-2 cases by dividing the total numbers by children aged 0-18 in Finland in 2020, according to Statistics Finland. The MIS-C incidence rates, and 95% CIs, were calculated per 1000 laboratoryconfirmed SARS-CoV-2 cases for the three-week periods from 1 January 2020 to 31 December 2020. This enabled us to examine the impact of the COVID-19 epidemic on the occurrence of Kawasaki disease.

We also performed an interrupted time series, which is a quasiexperimental design that evaluates changes on longitudinal data in relation to an intervention point. In this case, the intervention point was the start of the pandemic, including the need for social distancing. 11 The outcome was the quarterly number of Kawasaki disease cases each year from 2016 to 2020. We chose the date 16 March as the cut-off point for our pre-pandemic and pandemic data, as that is when Finland declared a state of emergency. Our time series included an intercept time variable, which was 20 three-month periods, and a period variable. Seasonality was adjusted using a Fourier term, and over-dispersion of data was controlled by scaled parameters with Pearson's chi-square test. The goodness of fit of model was evaluated by the Hosmer-Lemeshow chi-square test (p=0.448).

Autocorrelation was graphically examined, but it was not detected after the data were adjusted for seasonality. 11 We used the most feasible program for each statistical analysis, because all the statistical analyses were not available in one program.

The differences between the two proportions were tested with a standard normal deviate test available in StatsDirect statistical software 3 (StatsDirect Ltd). The data management and calculation of basic statistics were conducted using SPSS, version 27 (IBM Corp), and the 95% CI for rates and proportion differences were calculated using StatsDirect statistical software 3 (StatsDirect Ltd). ITS analysis was performed using Stata 16 (StataCorp LLC), and the incidence rates were created using OriginPro 2020 (OriginLab Corporation). 

This nationwide register-based study showed that MIS-C was a rare complication of the SARS-CoV-2 infection in children. The occurrence of Kawasaki disease markedly decreased during the COVID-19 pandemic, coinciding with a reduced number of respiratory infections in children. This was probably due to social distancing. 13, 14 The Furthermore, the reduced occurrence of Kawasaki disease coincided with the reduced respiratory infections in children and in adolescents in the same population. This was in line with several studies that reported that viral respiratory infections had decreased by 60%-70% in the population due to social distancing. 13, 14, 19, 20 Thus, the reduced transmission of microbes other than SARS-CoV-2 may explain the observed decreased incidence of Kawasaki disease in the present study. Our finding was in line with a study from six hospitals in Japan, which showed a possible 27% reduction in Kawasaki disease, with an incidence rate ratio of 0.73 (95% CI: 0.48-1.10) during the COVID-19 pandemic. 21 The aetiopathogenesis of Kawasaki disease Year Incidence rate of Kawasaki per three month periods Predicted trend of incidence rate has been extensively studied but is not fully understood. It appears to result from an interplay between genetic susceptibility and an in- has not been replicated in other studies. 24 The idea that respiratory viruses are the main triggers of Kawasaki disease is supported by findings from its clear seasonal cycle, which is similar to that of respiratory infections, but the data are insufficient to prove its involvement with coronaviruses in general. 22, 25, 26 The present study had several strengths. This was a large nationwide study that used comprehensive data from high-quality national registers that also covered the periods before the COVID-19

pandemic. In addition, we performed a time series analysis, which has rarely been used to compare Kawasaki disease-like diagnoses before, and during, the COVID-19 pandemic. Since August 2020, Finland has strongly recommended free, national and easily available testing for all children with symptoms, no matter how mild they are. This means that we were able to estimate the total number of SARS-CoV-2 infections in the study population better than most previous reports of MIS-C patient clusters during the COVID-19 pandemic.

In addition to the register-based data, we retrieved all MIS-C cases directly from the five university hospitals with paediatric intensive care units in Finland to ensure they had all been included in that data. We also present the changes in the epidemiology of common respiratory infections in the study population.

Our register-based study had some limitations. These included the lack of a specific ICD-10 code for MIS-C from the start of the COVID-19 emergency, which may have affected the accuracy of 

Hyperinflammatory shock in children during COVID-19 pandemic

Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19

Novel coronavirus infection in hospitalized infants under 1 year of age in China

Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic

Multisystem inflammatory syndrome in U.S. Children and adolescents

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Multisystem inflammatory syndrome in children in New York state

Multisystem inflammatory syndrome in children: an international survey

Severe coronavirus disease-2019 in children and young adults in the Washington, DC. Metropolitan Region

Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis

Interrupted time series regression for the evaluation of public health interventions: a tutorial

Emergency preparedness and response: Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease

Closing Finnish schools and day care centres had a greater impact on primary care than secondary care emergency department visits

Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study

Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering

The impact of the lockdown and the re-opening of schools and day cares on the epidemiology of SARS-CoV-2 and other respiratory infections in children -A nationwide register study in Finland

The Impact of Social Distancing for COVID-19 Upon Diagnosis of Kawasaki Disease

Assessment of pediatric admissions for Kawasaki disease or infectious disease during the COVID-19 State of Emergency in Japan

Patient age and the seasonal pattern of onset of Kawasaki's disease

Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan

Association between a novel human coronavirus and Kawasaki disease

Seasonality and temporal clustering of Kawasaki syndrome

Seasonality of Kawasaki disease: a global perspective

How to cite this article

Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis

the register-based data. Finally, the low number of MIS-C cases did not allow us to carry out analyses to compare the characteristics of MIS-C and Kawasaki disease patients.

This nationwide register-based study showed that MIS-C was a rare complication of the SARS-CoV-2 infection in children. The occurrence of Kawasaki disease decreased during the COVID-19 study period and coincided with a reduced number of respiratory infections due to social distancing. This finding suggests that transmissible microbes play an important role in the pathogenesis of Kawasaki disease.

The authors have no conflicts of interest to declare.

https://orcid.org/0000-0002-0812-8530Hanna Pasma https://orcid.org/0000-0002-7956-2318Terhi Tapiainen https://orcid.org/0000-0001-5433-4207